Form 4: Aspen Aerogels CEO Donald Young Executes Stock Options and Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Donald Young, President and CEO of Aspen Aerogels, exercised stock options and sold shares to cover tax withholding obligations, according to a recent SEC Form 4 filing.
Summary
- Donald R. Young, the President and CEO of Aspen Aerogels, executed multiple transactions involving the company's common stock on May 28 and May 29, 2024.
- These transactions included the exercise of stock options and the sale of common stock.
- The sales were conducted to satisfy tax withholding obligations related to the exercise of these stock options.
- The transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on February 26, 2024.
- On May 28, 2024, Young exercised options to purchase 259,671 shares at $10.78, 108,105 shares at $7.54, and 26,577 shares at $6.40.
- Also on May 28, 2024, he sold 230,658 shares at an average price of $29.18 and 26,286 shares at an average price of $29.72.
- On May 29, 2024, Young exercised options to purchase 296,771 shares at $6.40 and sold 176,746 shares at an average price of $29.38.
- Following these transactions, Young directly owns 622,880 shares of common stock, which includes 418,398 shares of Common Stock, 47,532 Restricted Stock Units and 156,950 shares of Restricted Stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by an insider. It doesn't inherently convey positive or negative sentiment, as the transactions are related to tax obligations and a pre-existing trading plan.
Industry Context
Insider transactions are common and closely monitored, providing insights into management's perspective on the company's valuation and future prospects. This filing is a routine disclosure and doesn't necessarily indicate a change in the company's outlook.
Stakeholder Impact
- The stock sales could exert downward pressure on the stock price in the short term, but the impact is likely to be minimal given the pre-planned nature of the transactions.
Key Dates
| Date | Description |
|---|---|
| 2015/12/11 | Reporting person previously disclosed the grant of an aggregate of 454,926 options. |
| 2024/02/26 | Date the Rule 10b5-1 trading plan was adopted. |
| 2024/05/28 | Date of multiple stock option exercises and sales. |
| 2024/05/29 | Date of additional stock option exercises and sales. |
| 2024/09/10 | Expiration date for some stock options. |
| 2025/03/11 | Expiration date for some stock options. |
| 2025/12/11 | Expiration date for some stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.